| |
Overview
HeadlinesNo recent Headlines for this stock. Business Background AC Immune SA is a clinical stage biopharmaceutical company. It is engaged in leveraging its two proprietary technology platforms to discover, design and develop novel, proprietary medicines for treatment of neurodegenerative diseases associated with protein misfolding.
| |